Revelation Biosciences, Inc.Revelation Biosciences, Inc.Revelation Biosciences, Inc.

Revelation Biosciences, Inc.

No trades
See on Supercharts

REVB fundamentals

An in-depth look to Revelation Biosciences, Inc. operating, investing, and financing activities

REVB free cash flow for Q3 24 is -9.27 M USD. For 2023, REVB free cash flow was -7.29 M USD and operating cash flow was -7.29 M USD.

Q4 '19
Q1 '20
Q2 '20
Q3 '20
Q4 '20
Q1 '21
Q2 '21
Q3 '21
Q4 '21
Q1 '22
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
‪0.00‬
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: USD
Q4 '19
Q1 '20
Q2 '20
Q3 '20
Q4 '20
Q1 '21
Q2 '21
Q3 '21
Q4 '21
Q1 '22
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
TTM
Free cash flowYoY growth